Emerging Inflammatory Bowel disease (IBD) demographics, phenotype and treatment in South Asia, South-East Asia, and the Middle East.
Data collection started in 2018.
Results presented in Nov 2018 (IBD-ENC workshop)
Future projects discussed
Website development /paper publication planned.
Manuscript submitted - under review (July 2020)
The Story of An Emerging Disease
UC vs CD
Epidemiologically incidence of CD increases as IBD evolves in a region
Typically incidence of UC precedes onset of CD by a few decades
There is diagnostic delay
Left sided colitis is common
Most A2: 17 - 40 Years Age Group
L3: Ileocolonic most common
B1: Mostly Inflammatory
Biologic usage is limited
Emperical Anti Tubercular Therapy (ATT) is often required
IBD's are chronic lifelong diseases
IBDENC can perhaps provide many answers:
Identifying environmental risk factors by comparing natives and migrants, rural and urban populations of same genetic profile & different ethnicity groups in diverse socioeconomic conditions.
Increasing awareness of IBD across the region.
Developing the best practice strategies for the region.